Pegasys® Plus Ribavirin in Thalassemic Patients With Hepatitis C Virus Infection

NCT00707850 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C
Thalassemia

Interventions

DRUG: PEGASYS® (Peginterferon Alfa-2a (40KD)) Plus COPEGUS® (Ribavirin)

Sponsor

Baqiyatallah Medical Sciences University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]